Osteoporosis medications improve bone health in men with prostate cancer receiving androgen deprivation therapy

Both biophosphonates and denosumab improve bone mineral density (BMD) in men with nonmetastatic prostate cancer who are receiving androgen deprivation therapy (ADT).
For more view http://ift.tt/2vg3PIp
By MEDIX LAB. Credit- medicalnewstoday

Advertisements